The Center for the Biology of Chronic Disease

Home	About	Nobel	Donate
The Book	Meetings	Grants	Contact

Stephen L. Carrithers, PhD

Assistant Professor of Medicine, Division of Infectious Diseases, Department of Internal Medicine, University of Kentucky

COMMENTS

I appreciate some of the responses you have sent me by other reviewers. Although I am not finished yet (due to some untimely grant proposals), I am thoroughly enjoying Dr. Polansky's book, especially the technical notes on signaling and drug-induced molecular disruptions. I can see where many teaching faculty of various basic science graduate school departments will be interested in referencing and even deriving lectures from this collection of writings. Lastly, this book has sparked the interest of some of my current graduate students, and now sharing the book has become somewhat of a competition within our own laboratory.

BIOGRAPHY

Stephen L. Carrithers, PhD is currently an Assistant Professor in Internal Medicine, Division of Infectious Diseases at the University of Kentucky, Chandler Medical Center and a Research Health Science Specialist in the Department of Veterans Affairs. He earned his Doctorate in Biochemistry and Molecular Biology at the University of Louisville, Health Sciences Center and completed his Postdoctoral Fellowship in Clinical Pharmacology at Thomas Jefferson University in Philadelphia followed by a research-training professorship in the Kidney Disease Program, Division of Nephrology, University of Louisville. He has authored over 40 scientific publications and has been awarded grants from the National Institutes of Health, American Cancer Society, American Heart Association, and the Veterans Administration. Dr. Carrithers has also helped start and consult for three biotechnology companies and currently serves as the Director of Molecular Diagnostics for Sequelae, Inc., a biotechnology company located in Lexington, Kentucky that focuses on vaccine development and novel diagnostics for HIV and emerging infectious diseases as well as therapeutics for gastrointestinal and renal disease. He has served as an ad hoc reviewer for various scientific and clinical journals such as the Proceeding of the National Academy of Sciences USA, American Journal of Physiology, and Current Drug Targets Immune, Endocrine & Metabolic Disorders. Dr. Carrithers is the co-inventor of two scientific patents and a series of invention disclosures and is also a member of Marquis Who's Who in Science and Engineering. Dr. Carrithers' scientific interests include development of novel anticancer drugs based on targeting specific checkpoints within various intracellular signal transduction cascades and the molecular and physiological mechanisms of natriuretic peptide-hormones.

MORE REVIEWS